Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction

被引:0
作者
Fabio Bertacchini
Claudia Agabiti Rosei
Giacomo Buso
Sara Cappellini
Deborah Stassaldi
Carlo Aggiusti
Massimo Salvetti
Anna Paini
Carolina De Ciuceis
Maria Lorenza Muiesan
机构
[1] University of Brescia,Department of Clinical and Experimental Sciences, 2a Medicina
来源
High Blood Pressure & Cardiovascular Prevention | 2022年 / 29卷
关键词
Diastolic dysfunction; Arterial hypertension; Antihypertensive treatment; Heart failure preserved ejection fraction;
D O I
暂无
中图分类号
学科分类号
摘要
Arterial hypertension represents an important risk factor for the development of cardiac, vascular and renal events, predisposing to heart failure, acute coronary syndromes, peripheral artery disease, stroke, and chronic renal disease. Arterial hypertension leads to the development of subclinical hypertension mediated organ damage (HMOD) which has prognostic relevance and may influence the choice of treatment options. Alterations of cardiac structure and function represent the more widely assessed form of HMOD. This manuscript will focus on the diagnostic opportunities, prognostic significance and treatment of diastolic dysfunction alterations
引用
收藏
页码:585 / 593
页数:8
相关论文
共 332 条
  • [1] Marwick TH(2015)Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger Eur Heart J Cardiovasc Imaging 16 577-605
  • [2] Gillebert TC(2016)Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 17 1321-1360
  • [3] Aurigemma G(2018)2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension J Hypertens 36 1953-2041
  • [4] Chirinos J(2020)Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography JACC Cardiovasc Imaging 13 228-244
  • [5] Derumeaux G(2019)Recent advances in imaging of hypertensive heart disease Curr Hypertens Rep 21 3-960
  • [6] Nagueh SF(2017)Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH) Eur Heart J Cardiovasc Imaging 18 945-2550
  • [7] Smiseth OA(2007)How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2539-411
  • [8] Appleton CP(2013)Alterations in early filling dynamics predict the progression of compensated pressure overload hypertrophy to heart failure better than abnormalities in midwall systolic shortening Clin Exp Hypertens 35 401-1545
  • [9] Byrd BF(2021)Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension J Hypertens 39 1522-184
  • [10] Dokainish H(2002)Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 15 167-159